Hypha LabsFUNI Gross Margin % is 0.00% as of Mar. 2026. The stock has 2 warning signs investors should review. Among 195 Medical Diagnostics & Research companies, Hypha Labs ranks worse than 512820% on this metric.
The historical rank and industry rank for Hypha Labs's Gross Margin % or its related term are showing as below:
During the past 13 years, the highestGross Margin % of Hypha Labs was 53.60%. The lowest was 27.11%. And the median was 31.91%.
FUNI's Gross Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 50.97 * Ranked among companies with meaningful Gross Margin % only.
Hypha Labs had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Hypha Labs was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Hypha Labs had a gross margin of N/A% for the quarter that ended in Mar. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Hypha Labs Gross Margin % Related Terms
Hypha Labs Gross Margin % Historical Data
* Premium members only.
The historical data trend for Hypha Labs's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FUNI vs IVRO, IDTA, NSTM: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Hypha Labs's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hypha Labs Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Hypha Labs's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Hypha Labs (FUNI) has a Gross Margin % of 0.00% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Hypha Labs and its competitors. Over the past decade, Hypha Labs' Gross Margin % has ranged from 27.11 to 53.60. According to the industry distribution chart, Hypha Labs ranks #999999 out of 195 companies in the Medical Diagnostics & Research industry.
Is Hypha Labs' Gross Margin % too high?
Hypha Labs' current Gross Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 27.11 to a high of 53.60. Based on the distribution chart, Hypha Labs ranks #999999 out of 195 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Hypha Labs' Gross Margin % compare to IVRO and IDTA?
According to the Medical Diagnostics & Research industry distribution chart, Hypha Labs ranks #999999 out of 195 companies for Gross Margin %. This places Hypha Labs in the lower half of its industry. The industry median Gross Margin % is 50.97. Historically, Hypha Labs' own Gross Margin % has ranged from 27.11 to 53.60 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 50.97, based on 195 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Hypha Labs and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 50.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypha Labs's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypha Labs stock overvalued right now?
Hypha Labs (FUNI) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Hypha Labs (FUNI), the current Gross Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hypha Labs Inc engaged in the research, development, and commercialization of the Hypha Micropearl accelerator, an in-home, web-based, computer-controlled bioreactor designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company's easy-to-use device, together with replaceable cartridges ordered through its exclusive app, safely and effectively produced enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contained active mushroom ingredients in a concentrated, easy-to-handle, tasteless, and odorless form that could be incorporated into various foods and beverages without altering flavor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FUNI has been successfully added to your 